Cargando…

Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells

Accumulating evidence indicates that a small subset of cancer cells, termed the tumor-initiating cells or cancer stem cells (CSCs), construct a reservoir of self-sustaining cancer cells with the characteristic ability to self-renew and maintain the tumor mass. The CSCs play an important role in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Liang, Zhang, Lin, Yang, Lin, Li, Hui, Li, Runmei, Yu, Jinpu, Yang, Lili, Wei, Feng, Yan, Cihui, Sun, Qian, Zhao, Hua, Yang, Fan, Jin, Hao, Wang, Jian, Wang, Shizhen Emily, Ren, Xiubao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399041/ https://www.ncbi.nlm.nih.gov/pubmed/28484448 http://dx.doi.org/10.3389/fimmu.2017.00404

Ejemplares similares

Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy
por: Yang, Yan, et al.
Publicado: (2021)

Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
por: Hui, Zhenzhen, et al.
Publicado: (2015)

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
por: Lin, Fangzhen, et al.
Publicado: (2021)

CD47 as a promising therapeutic target in oncology
por: Zhao, Hai, et al.
Publicado: (2022)

CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals
por: Li, Yang, et al.
Publicado: (2022)

Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T Cells In Situ and Lymph Node Metastasis
por: Yu, Jinpu, et al.
Publicado: (2011)

A fully human anti-CD47 blocking antibody with therapeutic potential for cancer
por: Zeng, Dadi, et al.
Publicado: (2016)

Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2
por: Tian, Xiao, et al.
Publicado: (2017)

miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
por: Xi, Qing, et al.
Publicado: (2020)

Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance
por: Yang, Mei, et al.
Publicado: (2022)

Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
por: Jiang, Mengmeng, et al.
Publicado: (2017)

Potential New Cancer Immunotherapy: Anti-CD47-SIRPα Antibodies
por: Lu, Quansheng, et al.
Publicado: (2020)

Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
por: Yu, Lan, et al.
Publicado: (2021)

Comparison of dynamic changes in the peripheral CD8(+) T cells function and differentiation in ESCC patients treated with radiotherapy combined with anti-PD-1 antibody or concurrent chemoradiotherapy
por: Wei, Hui, et al.
Publicado: (2022)

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
por: Zeller, Tobias, et al.
Publicado: (2022)

Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
por: Zhao, Hua, et al.
Publicado: (2018)

CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation
por: Okunuki, Yoko, et al.
Publicado: (2021)

Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy
por: Wang, Kaiyuan, et al.
Publicado: (2017)

Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data
por: Son, Ji, et al.
Publicado: (2022)

New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms
por: Shen, Meng, et al.
Publicado: (2018)

Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation
por: Hu, Guorong, et al.
Publicado: (2019)

Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
por: Liu, Jie, et al.
Publicado: (2015)

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
por: Wang, Hongfei, et al.
Publicado: (2020)

Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity
por: Qu, Tailong, et al.
Publicado: (2022)

Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
por: Yang, Hongcheng, et al.
Publicado: (2019)

Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
por: Hu, Jinyang, et al.
Publicado: (2020)

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer
por: Cao, Xu, et al.
Publicado: (2021)

CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism
por: Tao, Hui-Chao, et al.
Publicado: (2020)

Regulation of CD47 expression in cancer cells
por: Huang, Can-Yu, et al.
Publicado: (2020)

Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs
por: Hui, Zhenzhen, et al.
Publicado: (2021)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Lung cancer-associated mesenchymal stem cells promote tumor metastasis and tumorigenesis by induction of epithelial–mesenchymal transition and stem-like reprogram
por: Yan, Cihui, et al.
Publicado: (2021)

Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity
por: Xi, Qing, et al.
Publicado: (2020)

Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
por: Zhang, Wenting, et al.
Publicado: (2020)

Memory stem T cells generated by Wnt signaling from blood of human renal clear cell carcinoma patients
por: Yan, Cihui, et al.
Publicado: (2019)

CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies
por: Sun, Jennifer, et al.
Publicado: (2021)

CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra low density cancer epitopes
por: Mathias, Melissa D., et al.
Publicado: (2017)

Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis
por: Rodríguez-Jiménez, Pedro, et al.
Publicado: (2019)

CD24-Fc suppression of immune related adverse events in a therapeutic cancer vaccine model of murine neuroblastoma
por: Wu, Xiaofang, et al.
Publicado: (2023)

Chemoradiotherapy-Induced CD4(+) and CD8(+) T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma
por: Chen, Xi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1moh97jv1iuufvejfarkd77oes